rs201874958
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006206.6(PDGFRA):c.3098A>T(p.Asp1033Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000576 in 1,614,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006206.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDGFRA | ENST00000257290.10 | c.3098A>T | p.Asp1033Val | missense_variant | Exon 22 of 23 | 1 | NM_006206.6 | ENSP00000257290.5 | ||
ENSG00000282278 | ENST00000507166.5 | c.2378A>T | p.Asp793Val | missense_variant | Exon 23 of 24 | 2 | ENSP00000423325.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152170Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251264Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135802
GnomAD4 exome AF: 0.0000609 AC: 89AN: 1461856Hom.: 0 Cov.: 32 AF XY: 0.0000729 AC XY: 53AN XY: 727230
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152288Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74456
ClinVar
Submissions by phenotype
Ovarian cancer Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.D1033V variant (also known as c.3098A>T), located in coding exon 21 of the PDGFRA gene, results from an A to T substitution at nucleotide position 3098. The aspartic acid at codon 1033 is replaced by valine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Gastrointestinal stromal tumor Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at